IRCT201102265905N1已完成未知
Intraocular Pressure Lowering Effect of 0.005% Latanoprost With Two Different Dosing Regimen
Eye research center,Rassoul Akram Hospital, Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 no limit（—）
- 性别
- All
入选标准
- •The inclusion criteria are: Age =30 years, IOP =22 and =32 mmHg without any IOP lowering medication, cup to disc ratio =0.6, mean deviation of = -6 decibel in perimetry and open angles on gonioscopy. Patients with a history of prior ocular surgery, uveitis, herpetic keratitis, and allergy to latanoprost are excluded
排除标准
- 未提供
研究者
相似试验
已完成
不适用
A study of the intraocular pressure lowering effect of topical application of ripasudil in clinical practiceGlaucomaJPRN-UMIN000025466Kobe University Graduate School of Medicine130
尚未招募
不适用
Effect of pressure reducing effect of Ripasudil eye drops in patients with high pressure within the eyeCTRI/2022/09/045191Sankara eye hospital
已完成
不适用
Comparison of intraocular pressure lowering effects among four prostaglandin analogues: parallel administration to the bilateral eyes of normal subjects.glaucoma, ocular hypertensionJPRN-UMIN000003810Department of Ophthalmology, Houju Memorial Hospital25
已完成
不适用
Evaluation of the Intraocular pressure lowering effect of Tafluprost and Latanoprost on normal tension GlaucomaGlaucomaJPRN-UMIN000002017Department of ophthalmology, Kyoto Prefectural University of Medicine30
尚未招募
不适用
Comparison of the lowering intraocular pressure after trabeculotomy between patients with and without response to Ripasudil.1. Glaucoma 2. Ocular hypertentionJPRN-UMIN000023227Department of Ophthalmology Hokkaido university Graduate School of Medicine40